BMC Cancer

official impact factor 3.15

Open Access Highly Access Pre-publication history

Digitoxin medication and cancer; case control and internal dose-response studies

Johan Haux*, Olbjørn Klepp, Olav Spigset and Steinar Tretli

BMC Cancer 2001, 1:11 doi:10.1186/1471-2407-1-11

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 01 May 2001
Reviewer's Report Richard Havlik 07 Jun 2001
Resubmission - Version 2 Manuscript Author's comment 04 Jul 2001
Resubmission - Version 3 Manuscript Author's comment 04 Jul 2001
Resubmission - Version 4 Manuscript 09 Aug 2001
Resubmission - Version 5 Manuscript 10 Aug 2001
Published 10 Aug 2001